Position
Fidelity in BridgeBio Pharma, Inc.
Back to the book · All holders of BBIO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $30.7M$6.68 → $8.01
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 33.4M | $234.6M | — | — | — | 0.0% |
| Q1 2026 | 33.4M | $223.4M | $6.68 | −$11.9M | $623.8K | 0.0% |
| Q2 2026 | 23M | $184.4M | $8.01 | $30.7M | −$69.7M | 0.0% |